Osborne CK - Search Results

1

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase.

Gutierrez MC, Detre S, Johnston S, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Dowsett M. Gutierrez MC, et al. Among authors: osborne ck. J Clin Oncol. 2005 Apr 10;23(11):2469-76. doi: 10.1200/JCO.2005.01.172. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753463

2

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL. Allred DC, et al. Among authors: osborne ck. Hum Pathol. 1992 Sep;23(9):974-9. doi: 10.1016/0046-8177(92)90257-4. Hum Pathol. 1992. PMID: 1355464

3

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L, et al. Allred DC, et al. Among authors: osborne ck. J Clin Oncol. 1992 Apr;10(4):599-605. doi: 10.1200/JCO.1992.10.4.599. J Clin Oncol. 1992. PMID: 1548522 Clinical Trial.

4

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors.

Wiebe VJ, Osborne CK, McGuire WL, DeGregorio MW. Wiebe VJ, et al. Among authors: osborne ck. J Clin Oncol. 1992 Jun;10(6):990-4. doi: 10.1200/JCO.1992.10.6.990. J Clin Oncol. 1992. PMID: 1588380

5

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

Osborne CK, Wiebe VJ, McGuire WL, Ciocca DR, DeGregorio MW. Osborne CK, et al. J Clin Oncol. 1992 Feb;10(2):304-10. doi: 10.1200/JCO.1992.10.2.304. J Clin Oncol. 1992. PMID: 1732430

6

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M. Osborne CK, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82. doi: 10.1093/jnci/83.20.1477. J Natl Cancer Inst. 1991. PMID: 1920493

7

Tamoxifen in premenopausal patients with metastatic breast cancer: a review.

Sunderland MC, Osborne CK. Sunderland MC, et al. Among authors: osborne ck. J Clin Oncol. 1991 Jul;9(7):1283-97. doi: 10.1200/JCO.1991.9.7.1283. J Clin Oncol. 1991. PMID: 2045868 Review.

8

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, Osborne CK. Arteaga CL, et al. Among authors: osborne ck. J Clin Invest. 1989 Nov;84(5):1418-23. doi: 10.1172/JCI114315. J Clin Invest. 1989. PMID: 2553774 Free PMC article.

9

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

Clark GM, Osborne CK, McGuire WL. Clark GM, et al. Among authors: osborne ck. J Clin Oncol. 1984 Oct;2(10):1102-9. doi: 10.1200/JCO.1984.2.10.1102. J Clin Oncol. 1984. PMID: 6491696

10

Aberrant subcellular localization of BRCA1 in breast cancer.

Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK, Lee WH. Chen Y, et al. Among authors: osborne ck. Science. 1995 Nov 3;270(5237):789-91. doi: 10.1126/science.270.5237.789. Science. 1995. PMID: 7481765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters